Latest Cipla stock price
Cipla P/E Ratio
CIPLA • P/E ratio trend, valuation band, and sector comparison — all formatted to support journal-based trading review.
Current P/E Ratio
22.75
Moderate Valuation
High - Growth expectations or overvalued
Current Valuation Metrics
P/E Ratio
22.75
Current Price
₹1465.70
EPS (TTM)
₹65.29
Exchange
NSE
Valuation Signal
Signal
Overvalued
Historical Avg
25.31
Historical Range
17.15 - 36.79
Percentile
28.6%
Sector Context
Sector Average
53.63
Sector Median
31.12
Sector Rank
#11 of 131
Sector Percentile
8.4%
Earnings Breakdown (TTM)
TTM EPS
₹64.06
Sept 2025
₹16.73
Mar 2025
₹15.13
Key P/E Ratio Insights for Cipla
- Trading at discount to sector average PE of 53.63
View the CIPLA equity price for detailed stock performance.
P/E Ratio Historical Trend for Cipla
Historical P/E ratio trend based on annual earnings data. Lower P/E ratios may indicate undervaluation, while higher ratios suggest growth expectations.
Related Pages for Cipla
Additional stock information and data for CIPLA
Historical P/E Ratio Data
| Year | P/E Ratio | EPS (₹) | Year-end Price (₹) | Exchange | Valuation |
|---|---|---|---|---|---|
| 2024 | 20.25 | 61.79 | ₹1251.00 | NSE | Moderate |
| 2023 | 23.31 | 45.94 | ₹1070.95 | NSE | Moderate |
| 2022 | 28.46 | 32.7 | ₹930.50 | NSE | High |
| 2021 | 25.96 | 31.84 | ₹826.60 | NSE | High |
| 2020 | 17.15 | 27.75 | ₹475.90 | NSE | Moderate |
| 2019 | 25.28 | 20.69 | ₹523.05 | NSE | High |
| 2018 | 36.79 | 16.62 | ₹611.50 | NSE | High |
Sector P/E Ratio Comparison
Comparing Cipla with other companies in Healthcare sector
Sector Average
53.63
Sector Median
31.12
Lowest P/E
1.5
Highest P/E
628.04
Companies
131
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Welcure Drugs & Pharmace… | WELCURE | 1.5 | ₹51 | Low |
| Ind Swift Laboratories | INDSWFTLAB | 3.18 | ₹733 | Low |
| Murae Organisor | MURAE | 3.86 | ₹55 | Low |
| Fermenta Biotech | FERMENTA | 9.01 | ₹1,010 | Low |
| Zenith Drugs | ZENITHDRUG | 9.06 | ₹84 | Low |
| Galaxy Medicare | GML | 9.5 | ₹32 | Low |
| Balaxi Pharmaceuticals | BALAXI | 10.06 | ₹139 | Low |
| Natco Pharma | NATCOPHARM | 10.8 | ₹17,006 | Low |
| Vasundhara Rasayans | VRL | 11.3 | ₹51 | Low |
| Mohini Health & Hygiene | MHHL | 11.84 | ₹69 | Low |